Results 101 to 110 of about 49,191 (297)

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

open access: yes, 2015
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
Zullo, Angelo   +16 more
core   +5 more sources

A Proposal to Center Relevance in Applied Linguistics Research: The Relevance‐to‐Practice (RTP) Framework

open access: yesTESOL Quarterly, EarlyView.
Abstract Considering applied linguistics as a problem‐centered discipline, we address an enduring challenge in the field: the need to ensure that research provides findings that can contribute to solving everyday challenges faced by language practitioners.
Hyun‐Bin Hwang, Matthew D. Coss
wiley   +1 more source

Chronic urticaria.

open access: yesThe Western journal of medicine, 1990
Urticaria affects 15% to 20% of the population once or more during a lifetime. Chronic urticaria is a frequent recurrent eruption over a period greater than 6 weeks; the cause remains a mystery in more than 75% of cases. Urticaria and angioedema may be produced by immunologic or nonimmunologic means.
B A, Burrall, G M, Halpern, A C, Huntley
openaire   +3 more sources

Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO‐2b/3 and ALLEGRO‐LT Clinical Studies for Alopecia Areata

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Ritlecitinib is an oral JAK3/TEC family kinase inhibitor approved for individuals aged ≥ 12 years with severe alopecia areata. Here we report interim efficacy and safety results with ritlecitinib up to Month 24 in the Asian subpopulation from the ALLEGRO phase 2b/3 and ALLEGRO‐LT studies.
Rie Ueki   +13 more
wiley   +1 more source

Cost‐Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT The efficacy and safety of ritlecitinib, a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinase expressed in hepatocellular carcinoma (TEC) family kinases, have been demonstrated in the ALLEGRO phase 2b/3 trial that enrolled patients aged ≥ 12 years with alopecia areata (AA) and ≥ 50% scalp hair loss.
Akira Yuasa   +8 more
wiley   +1 more source

Dwelling in a post‐fallout landscape: re‐shaping and sustaining life in a former evacuation zone in Fukushima Habiter après la catastrophe : redonner forme au monde et entretenir la vie dans une ancienne zone évacuée à Fukushima

open access: yesJournal of the Royal Anthropological Institute, EarlyView.
This article explores the activities of daily life in a village neighbouring the TEPCO nuclear power plant in Fukushima. It argues that one of the potentials of taking a dwelling perspective – a phenomenological approach to living within the ecological and social environments – emerges most compellingly within a polluted landscape.
Tomoko Sakai
wiley   +1 more source

Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies

open access: yesCase Reports in Medicine, 2015
Chronic spontaneous urticaria is an itching skin disease characterised by wheals, angioedema, or both present for more than six weeks. Omalizumab is a humanized anti-IgE monoclonal antibody recently approved for treatment of chronic urticaria.
Misbah Nasheela Ghazanfar   +1 more
doaj   +1 more source

Brood parasitism reduces but does not prevent Bombus terrestris reproductive success

open access: yesInsect Science, EarlyView.
Graphical depiction of the colony splitting process. Throughout figures in this paper, results pertaining to host success are represented in blue, and cuckoo success is represented in red. Abstract Cuckoo bumblebees are obligate brood parasites that must invade a colony of their host bumblebee species in order to reproduce.
Sofia Dartnell, Lynn V. Dicks
wiley   +1 more source

Urticaria

open access: yesAllergy, Asthma & Clinical Immunology
Urticaria (hives) is a common disorder that may be associated with angioedema (swelling that occurs beneath the skin). It is generally classified as acute or chronic, and chronic urticaria is further classified as spontaneous or inducible Second ...
Moshe Ben-Shoshan   +3 more
doaj   +1 more source

خصوصيات بالينی و يافته‌های آزمايشگاهی ٢٧٤ بيمار دارای کهير مزمن و مرور مقالات [PDF]

open access: yes, 2013
زمينه و هدف: کهير از بيماری‌های شايع پوستی با شيوع 0.3 تا 11.3 درصد است. 20 درصد از مردم در طول زندگی به آن مبتلا می‌گردند. کهير در غالب موارد علت شناخته شده ای ندارد. هدف از اين مطالعه توصيف علائم بالينی، تست‌های آزمايشگاهي و مشخصات فردی تعداد 274 بيمار
خادملو, محمد   +2 more
core  

Home - About - Disclaimer - Privacy